126 related articles for article (PubMed ID: 1833226)
1. Heterogeneity amongst fibroblasts in the production of migration stimulating factor (MSF): implications for cancer pathogenesis.
Schor SL; Grey AM; Picardo M; Schor AM; Howell A; Ellis I; Rushton G
EXS; 1991; 59():127-46. PubMed ID: 1833226
[TBL] [Abstract][Full Text] [Related]
2. Mechanism of action of the migration stimulating factor produced by fetal and cancer patient fibroblasts: effect on hyaluronic and synthesis.
Schor SL; Schor AM; Grey AM; Chen J; Rushton G; Grant ME; Ellis I
In Vitro Cell Dev Biol; 1989 Aug; 25(8):737-46. PubMed ID: 2768134
[TBL] [Abstract][Full Text] [Related]
3. Migration stimulating factor (MSF): its structure, mode of action and possible function in health and disease.
Schor SL; Grey AM; Ellis I; Schor AM; Coles B; Murphy R
Symp Soc Exp Biol; 1993; 47():235-51. PubMed ID: 8165568
[TBL] [Abstract][Full Text] [Related]
4. Detection of migration stimulating activity in wound fluid.
Picardo M; Grey AM; McGurk M; Ellis I; Schor SL
Exp Mol Pathol; 1992 Aug; 57(1):8-21. PubMed ID: 1397194
[TBL] [Abstract][Full Text] [Related]
5. Antagonistic effects of TGF-beta 1 and MSF on fibroblast migration and hyaluronic acid synthesis. Possible implications for dermal wound healing.
Ellis I; Grey AM; Schor AM; Schor SL
J Cell Sci; 1992 Jul; 102 ( Pt 3)():447-56. PubMed ID: 1506427
[TBL] [Abstract][Full Text] [Related]
6. Purification of the migration stimulating factor produced by fetal and breast cancer patient fibroblasts.
Grey AM; Schor AM; Rushton G; Ellis I; Schor SL
Proc Natl Acad Sci U S A; 1989 Apr; 86(7):2438-42. PubMed ID: 2488545
[TBL] [Abstract][Full Text] [Related]
7. Inter- and intra-site heterogeneity in the expression of fetal-like phenotypic characteristics by gingival fibroblasts: potential significance for wound healing.
Irwin CR; Picardo M; Ellis I; Sloan P; Grey A; McGurk M; Schor SL
J Cell Sci; 1994 May; 107 ( Pt 5)():1333-46. PubMed ID: 7929639
[TBL] [Abstract][Full Text] [Related]
8. Foetal-to-adult transitions in fibroblast phenotype: their possible relevance to the pathogenesis of cancer.
Schor SL; Schor AM
J Cell Sci Suppl; 1987; 8():165-80. PubMed ID: 3332659
[TBL] [Abstract][Full Text] [Related]
9. Differential response of fetal and adult fibroblasts to cytokines: cell migration and hyaluronan synthesis.
Ellis I; Banyard J; Schor SL
Development; 1997 Apr; 124(8):1593-600. PubMed ID: 9108375
[TBL] [Abstract][Full Text] [Related]
10. Fibroblast subpopulations as accelerators of tumor progression: the role of migration stimulating factor.
Schor SL
EXS; 1995; 74():273-96. PubMed ID: 8527899
[TBL] [Abstract][Full Text] [Related]
11. Foetal and cancer patient fibroblasts produce an autocrine migration-stimulating factor not made by normal adult cells.
Schor SL; Schor AM; Grey AM; Rushton G
J Cell Sci; 1988 Jul; 90 ( Pt 3)():391-9. PubMed ID: 3253289
[TBL] [Abstract][Full Text] [Related]
12. Metabolic remodeling of the tumor microenvironment: migration stimulating factor (MSF) reprograms myofibroblasts toward lactate production, fueling anabolic tumor growth.
Carito V; Bonuccelli G; Martinez-Outschoorn UE; Whitaker-Menezes D; Caroleo MC; Cione E; Howell A; Pestell RG; Lisanti MP; Sotgia F
Cell Cycle; 2012 Sep; 11(18):3403-14. PubMed ID: 22918248
[TBL] [Abstract][Full Text] [Related]
13. Migration-stimulating factor: a genetically truncated onco-fetal fibronectin isoform expressed by carcinoma and tumor-associated stromal cells.
Schor SL; Ellis IR; Jones SJ; Baillie R; Seneviratne K; Clausen J; Motegi K; Vojtesek B; Kankova K; Furrie E; Sales MJ; Schor AM; Kay RA
Cancer Res; 2003 Dec; 63(24):8827-36. PubMed ID: 14695199
[TBL] [Abstract][Full Text] [Related]
14. The expression of migration stimulating factor, a potent oncofetal cytokine, is uniquely controlled by 3'-untranslated region-dependent nuclear sequestration of its precursor messenger RNA.
Kay RA; Ellis IR; Jones SJ; Perrier S; Florence MM; Schor AM; Schor SL
Cancer Res; 2005 Dec; 65(23):10742-9. PubMed ID: 16322219
[TBL] [Abstract][Full Text] [Related]
15. Multi-factorial modulation of IGD motogenic potential in MSF (migration stimulating factor).
Ellis IR; Jones SJ; Staunton D; Vakonakis I; Norman DG; Potts JR; Milner CM; Meenan NA; Raibaud S; Ohea G; Schor AM; Schor SL
Exp Cell Res; 2010 Sep; 316(15):2465-76. PubMed ID: 20403349
[TBL] [Abstract][Full Text] [Related]
16. Migration Stimulating Factor (MSF): Its Role in the Tumour Microenvironment.
Schor AM; Woolston AM; Kankova K; Harada K; Aljorani LE; Perrier S; Felts PA; Keatch RP; Schor SL
Adv Exp Med Biol; 2021; 1329():351-397. PubMed ID: 34664248
[TBL] [Abstract][Full Text] [Related]
17. Differential effects of TGF-beta1 on hyaluronan synthesis by fetal and adult skin fibroblasts: implications for cell migration and wound healing.
Ellis IR; Schor SL
Exp Cell Res; 1996 Nov; 228(2):326-33. PubMed ID: 8912726
[TBL] [Abstract][Full Text] [Related]
18. Subpopulations of fetal-like gingival fibroblasts: characterisation and potential significance for wound healing and the progression of periodontal disease.
Schor SL; Ellis I; Irwin CR; Banyard J; Seneviratne K; Dolman C; Gilbert AD; Chisholm DM
Oral Dis; 1996 Jun; 2(2):155-66. PubMed ID: 8957929
[TBL] [Abstract][Full Text] [Related]
19. Characterization of migration-stimulating factor (MSF): evidence for its role in cancer pathogenesis.
Schor SL; Schor AM
Cancer Invest; 1990; 8(6):665-7. PubMed ID: 2292062
[No Abstract] [Full Text] [Related]
20. Fibroblasts from cancer patients display a mixture of both foetal and adult-like phenotypic characteristics.
Schor SL; Schor AM; Rushton G
J Cell Sci; 1988 Jul; 90 ( Pt 3)():401-7. PubMed ID: 3253290
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
